ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch’s Membrane and Causes Its Structural Remodeling

References

• Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16. doi:10.1016/S2214-109X(13)70145-1.
   PubMed Web of Science ®Google Scholar
• Miller JW. Age-related macular degeneration revisited–piecing the puzzle: the LXIX Edward Jackson memorial lecture. Am J Ophthalmol. 2013;155(1):1–35 e13. doi:10.1016/j.ajo.2012.10.018.
   PubMed Web of Science ®Google Scholar
• Smith W, Assink J, Klein R, Mitchell P, Klaver CCW, Klein BEK, Hofman A, Jensen S, Wang JJ, De Jong PTVM. Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology. 2001;108:697–704. doi:10.1016/S0161-6420(00)00580-7.
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Shapiro H, Tuomi L, Webster M, Elledge J, Blodi B. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology. 2011;118(3):523–30. doi:10.1016/j.ophtha.2010.07.011.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Johnson M, Rudolf M, Huang J-D. The oil spill in ageing Bruch’s membrane. Br J Ophthalmol. 2011;95(12):1638–45. doi:10.1136/bjophthalmol-2011-300344.
   PubMed Web of Science ®Google Scholar
• Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988;2(5):552–77. doi:10.1038/eye.1988.106.
   PubMed Web of Science ®Google Scholar
• Green WR, Enger C. Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. Ophthalmology. 1993;100(10):1519–35. doi:10.1016/S0161-6420(93)31466-1.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Johnson M, Huang J-D, Rudolf M. Aging, age-related macular degeneration, and the Response-to-Retention of apolipoprotein B-containing lipoproteins. Prog Ret Eye Res. 2009;28(6):393–422. doi:10.1016/j.preteyeres.2009.08.001.
   PubMed Web of Science ®Google Scholar
• Sarks JP, Sarks SH, Killingsworth MC. Evolution of soft drusen in age-related macular degeneration. Eye. 1994;8(3):269–83. doi:10.1038/eye.1994.57.
   PubMedGoogle Scholar
• Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS, Milton RC, Bressler SB, Klein R. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123(11):1570–74. doi:10.1001/archopht.123.11.1570.
   PubMed Web of Science ®Google Scholar
• Spaide RF, Armstrong D, Browne R. Continuing medical education review: choroidal neovascularization in age-related macular degeneration–what is the cause? Retina. 2003;23(5):595–614. doi:10.1097/00006982-200310000-00001.
   PubMed Web of Science ®Google Scholar
• Sarks SH, Arnold JJ, Sarks JP, Gilles MC, Walter CJ. Prophylactic perifoveal laser treatment of soft drusen. Aust N Z J Ophthalmol. 1996;24(1):15–26. doi:10.1111/j.1442-9071.1996.tb01546.x.
   PubMedGoogle Scholar
• Sarks S, Cherepanoff S, Killingsworth M, Sarks J. Relationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007;48(3):968–77. doi:10.1167/iovs.06-0443.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Presley JB, Millican CL, Medeiros NE. Basal deposits and drusen in eyes with age-related maculopathy: Evidence for solid lipid particles. Exp Eye Res. 2005;80(6):761–75. doi:10.1016/j.exer.2004.09.017.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Johnson M. Structure, function, and pathology of Bruch’s membrane. In Ryan SJ, Schachat AP, Wilkinson CP, Hinton DR, Sadda S, Wiedemann P, editors. Retina. 1. 5th ed. London: Elsevier; 2013. p. 466–81.
   Google Scholar
• Li C-M, Chung BH, Presley JB, Malek G, Zhang X, Dashti N, Li L, Chen J, Bradley K, Kruth HS, et al. Lipoprotein-like particles and cholesteryl esters in human Bruch’s membrane: Initial characterization. Invest Ophthalmol Vis Sci. 2005;46(7):2576–86. doi:10.1167/iovs.05-0034.
   PubMed Web of Science ®Google Scholar
• Klaver CC, Kliffen M, Van Duijn CM, Hofman A, Cruts M, Grobbee DE, Van Broeckhoven C, De Jong PTVM. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet. 1998;63(1):200–06. doi:10.1086/301901.
   PubMed Web of Science ®Google Scholar
• Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. Faseb J. 2000;14(7):835–46.
   PubMed Web of Science ®Google Scholar
• Malek G, Li C-M, Guidry C, Medeiros NE, Curcio CA. Apolipoprotein B in cholesterol-containing drusen and basal deposits in eyes with age-related maculopathy. Am J Pathol. 2003;162(2):413–25. doi:10.1016/S0002-9440(10)63836-9.
   PubMed Web of Science ®Google Scholar
• Li C-M, Clark ME, Chimento MF, Curcio CA. Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. Invest Ophthalmol Vis Sci. 2006;47:3119–28. doi:10.1167/iovs.05-1446.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human Bruch’s membrane. Invest Ophthalmol Vis Sci. 2001;42(1):265–74.
   PubMed Web of Science ®Google Scholar
• Ruberti JW, Curcio CA, Millican CL, Menco BP, Huang JD, Johnson M. Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch’s membrane. Invest Ophthalmol Vis Sci. 2003;44(4):1753–59. doi:10.1167/iovs.02-0496.
   PubMed Web of Science ®Google Scholar
• Huang J-D, Presley JB, Chimento MF, Curcio CA, Johnson M. Age-related changes in human macular Bruch’s membrane as seen by quick-freeze/deep-etch. Exp Eye Res. 2007;85(2):202–18. doi:10.1016/j.exer.2007.03.011.
   PubMed Web of Science ®Google Scholar
• Spaide R, Ho-Spaide W, Browne R, Armstrong D. Characterization of peroxidized lipids in Bruch’s membrane. Retina. 1999;19:141–47. doi:10.1097/00006982-199902000-00010.
   PubMed Web of Science ®Google Scholar
• Armstrong D, Ueda T, Ueda T, Aljada A, Browne R, Fukuda S, Spengler R, Chou R, Hartnett M, Buch P, et al. Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis. 1998;2(1):93–104. doi:10.1023/A:1009010628371.
   PubMedGoogle Scholar
• Amaral J, Lee JW, Chou J, Campos MM, Rodriguez IR. 7-Ketocholesterol induces inflammation and angiogenesis in vivo: A novel rat model. PLoS One. 2013;8(2):e56099. doi:10.1371/journal.pone.0056099.
   PubMed Web of Science ®Google Scholar
• Rodriguez IR, Clark ME, Lee JW, Curcio CA. 7-ketocholesterol accumulates in ocular tissues as a consequence of aging and is present in high levels in drusen. Exp Eye Res. 2014;128:151–55. doi:10.1016/j.exer.2014.09.009.
   PubMed Web of Science ®Google Scholar
• Rudolf M, Clark ME, Chimento M, Li C-M, Medeiros NE, Curcio CA. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest Ophthalmol Vis Sci. 2008;49(3):1200–09. doi:10.1167/iovs.07-1466.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Balaratnasingam C, Messinger JD, Yannuzzi LA, Freund KB. Correlation of type 1 neovascularization associated with acquired vitelliform lesion in the setting of age-related macular degeneration. Am J Ophthalmol. 2015;160(5):1024–33e3. doi:10.1016/j.ajo.2015.08.001.
   PubMed Web of Science ®Google Scholar
• Zeng G, Taylor SM, McColm JR, Kappas NC, Kearney JB, Williams LH, Hartnett ME, Bautch VL. Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation. Blood. 2007;109(4):1345–52. doi:10.1182/blood-2006-07-037952.
   PubMed Web of Science ®Google Scholar
• Grossniklaus HE, Miskala PH, Green WR, Bressler SB, Hawkins BS, Toth C, Wilson DJ, Bressler NM. Histopathologic and ultrastructural features of surgically excised subfoveal choroidal neovascular lesions: Submacular surgery trials report no. 7. Arch Ophthalmol. 2005;123(7):914–21. doi:10.1001/archopht.123.7.914.
   PubMedGoogle Scholar
• Li C-M, Presley JB, Zhang X, Dashti N, Chung BH, Medeiros NE, Guidry C, Curcio CA. Retina expresses microsomal triglyceride transfer protein: Implications for age-related maculopathy. J Lipid Res. 2005;46(4):628–40. doi:10.1194/jlr.M400428-JLR200.
   PubMed Web of Science ®Google Scholar
• Zheng W, Reem R, Omarova S, Huang S, DiPatrec PL, Charvet C, Curcio CA, Pikuleva IA, Chaum E. Spatial distribution of the pathways of cholesterol homeostasis in human retina. PLoS ONE. 2012;7(5):e37926. doi:10.1371/journal.pone.0037926.
   PubMed Web of Science ®Google Scholar
• Li M, Jia C, Kazmierkiewicz KL, Bowman AS, Tian L, Liu Y, Gupta NA, Gudiseva HV, Yee SS, Kim M, et al. Comprehensive analysis of gene expression in human retina and supporting tissues. Hum Mol Genet. 2014;23(15):4001–14. doi:10.1093/hmg/ddu114.
   PubMed Web of Science ®Google Scholar
• Wang L, Li C-M, Rudolf M, Belyaeva OV, Chung BH, Messinger JD, Kedishvili NY, Curcio CA. Lipoprotein particles of intra-ocular origin in human Bruch membrane: an unusual lipid profile. Invest Ophthalmol Vis Sci. 2009;50:870–77. doi:10.1167/iovs.08-2376.
   PubMed Web of Science ®Google Scholar
• Pikuleva I, Curcio CA. Cholesterol in the retina: The best is yet to come. Prog Ret Eye Res. 2014;41(Jul):64–89. doi:10.1016/j.preteyeres.2014.03.002.
   PubMed Web of Science ®Google Scholar
• Johnson LV, Forest DL, Banna CD, Radeke CM, Maloney MA, Hu J, Spencer CN, Walker AM, Tsie MS, Bok D, et al. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc Natl Acad Sci U S A. 2011;108(45):18277–82. doi:10.1073/pnas.1109703108.
   PubMed Web of Science ®Google Scholar
• Pilgrim M, Lengyel I, Lanzirotti A, Newville M, Fearn S, Emri E, Knowles JC, Messinger JD, Read RW, Guidry C, et al. Sub-retinal pigment epithelial deposition of drusen components including hydroxyapatite in a primary cell culture model. Invest Ophthalmol Vis Sci. 2017;58(2):708–19. doi:10.1167/iovs.16-21060.
   PubMed Web of Science ®Google Scholar
• Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, Burdon KP, Hebbring SJ, Wen C, Gorski M, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48(2):134–43. doi:10.1038/ng.3448.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Johnson M, Huang J-D, Rudolf M. Apolipoprotein B-containing lipoproteins in retinal aging and age-related maculopathy. J Lipid Res. 2010;51(3):451–67. doi:10.1194/jlr.R002238.
   PubMed Web of Science ®Google Scholar
• Navab M, Anantharamaiah GM, Reddy ST, Fogelman AM. Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention. Nat Clin Pract Cardiovasc Med. 2006;3(10):540–47. doi:10.1038/ncpcardio0661.
   PubMedGoogle Scholar
• Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Yu N, Ansell BJ, Datta G, Garber DW, et al. Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol. 2005;25(7):1325–31. doi:10.1161/01.ATV.0000165694.39518.95.
   PubMed Web of Science ®Google Scholar
• Datta G, Chaddha M, Hama S, Navab M, Fogelman AM, Garber DW, et al. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J Lipid Res. 2001;42(7):1096–104.
   PubMed Web of Science ®Google Scholar
• Buga GM, Frank JS, Mottino GA, Hakhamian A, Narasimha A, Watson AD, Yekta B, Navab M, Reddy ST, Anantharamaiah GM, et al. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. J Lipid Res. 2008;49(1):192–205. doi:10.1194/jlr.M700433-JLR200.
   PubMed Web of Science ®Google Scholar
• Gupta H, Dai L, Datta G, Garber DW, Grenett H, Li Y, Mishra V, Palgunachari MN, Handattu S, Gianturco SH, et al. Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide. Circ Res. 2005;97(3):236–43. doi:10.1161/01.RES.0000176530.66400.48.
   PubMed Web of Science ®Google Scholar
• Anantharamaiah GM, Mishra VK, Garber DW, Datta G, Handattu SP, Palgunachari MN, Chaddha M, Navab M, Reddy ST, Segrest JP, et al. Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides. J Lipid Res. 2007;48(9):1915–23. doi:10.1194/jlr.R700010-JLR200.
   PubMed Web of Science ®Google Scholar
• Leman LJ, Maryanoff BE, Ghadiri MR. Molecules that mimic apolipoprotein A-I: Potential agents for treating atherosclerosis. J Med Chem. 2014;57(6):2169–96. doi:10.1021/jm4005847.
   PubMed Web of Science ®Google Scholar
• Li X, Chyu KY, Faria Neto JR, Yano J, Nathwani N, Ferreira C, Dimayuga PC, Cercek B, Kaul S, Shah PK. Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice. Circulation. 2004;110(12):1701–05. doi:10.1161/01.CIR.0000142857.79401.69.
   PubMed Web of Science ®Google Scholar
• Sharifov OF, Anantharamaiah GM, Gupta H. Effects of apoA-I mimetic peptide L-4F in LPS-mediated inflammation. In Anantharamaiah GM, Goldberg D, editors. Apolipoprotein mimetics in the management of human disease. Berlin: Springer; 2015. p. 63–88.
   Google Scholar
• Van Lenten BJ, Wagner AC, Jung C-L, Ruchala P, Waring AJ, Lehrer RI, Watson AD, Hama S, Navab M, Anantharamaiah GM, et al. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J Lipid Res. 2008;49(11):2302–11. doi:10.1194/jlr.M800075-JLR200.
   PubMed Web of Science ®Google Scholar
• Reddy ST, Navab M, Anantharamaiah GM, Fogelman AM. Apolipoprotein A-I mimetics. Curr Opin Lipidol. 2014;25(4):304–08. doi:10.1097/MOL.0000000000000092.
   PubMed Web of Science ®Google Scholar
• Smith JD. Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis. Curr Opin Investig Drugs. 2010;11(9):989–96.
   PubMedGoogle Scholar
• Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, Fogelman AM. Potential clinical utility of high-density lipoprotein-mimetic peptides. Curr Opin Lipidol. 2006;17(4):440–44. doi:10.1097/01.mol.0000236371.27508.d4.
   PubMed Web of Science ®Google Scholar
• Watson CE, Weissbach N, Kjems L, Ayalasomayajula S, Zhang Y, Chang I, Navab M, Hama S, Hough G, Reddy ST, et al. Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function. J Lipid Res. 2011;52(2):361–73. doi:10.1194/jlr.M011098.
   PubMed Web of Science ®Google Scholar
• Bloedon LT, Dunbar R, Duffy D, Pinell-Salles P, Norris R, DeGroot BJ, Movva R, Navab M, Fogelman AM, Rader DJ. Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients. J Lipid Res. 2008;49(6):1344–52. doi:10.1194/jlr.P800003-JLR200.
   PubMed Web of Science ®Google Scholar
• Dithmar S, Curcio C, Le N-A, Brown S, Grossniklaus H. Ultrastructural changes in Bruch’s membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci. 2000;41:2035–42.
   PubMed Web of Science ®Google Scholar
• Bretillon L, Acar N, Seeliger MW, Santos M, Maire MA, Juaneda P, Martine L, Gre´Goire S, Joffre C, Bron AM, et al. ApoB100,LDLR−/−Mice exhibit reduced electroretinographic response and cholesteryl esters deposits in the retina. Invest Ophthalmol Vis Sci. 2008;49(4):1307–14. doi:10.1167/iovs.07-0808.
   PubMed Web of Science ®Google Scholar
• Rudolf M, Mohi A, Dettbarn MC, Miura Y, Aherrahrou Z, Ranjbar M, Mutus B, Knobloch JKM. Detection of esterified cholesterol in murine Bruch’s membrane wholemounts with a perfringolysin O-based cholesterol marker. Invest Ophthalmol Vis Sci. 2014;55(8):4759–67. doi:10.1167/iovs.14-14311.
   PubMed Web of Science ®Google Scholar
• Fujihara M, Cano M, Handa JT. Mice that produce ApoB100 lipoproteins in the RPE do not develop drusen yet are still a valuable experimental system. Invest Ophthalmol Vis Sci. 2014;55(11):7285–95. doi:10.1167/iovs.14-15195.
   PubMed Web of Science ®Google Scholar
• Cousins SW, Espinosa-Heidmann DG, Alexandridou A, Sall J, Dubovy S, Csaky K. The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. Exp Eye Res. 2002;75(5):543–53. doi:10.1006/exer.2002.2047.
   PubMed Web of Science ®Google Scholar
• Toomey CB, Kelly U, Saban DR, Bowes Rickman C. Regulation of age-related macular degeneration-like pathology by complement factor H. Proc Natl Acad Sci U S A. 2015;112(23):E3040–9. doi:10.1073/pnas.1424391112.
   PubMed Web of Science ®Google Scholar
• Ong JM, Zorapapel NC, Aoki AM, Brown DJ, Nesburn AB, Rich KA, Kenney MC. Impaired electroretinogram (ERG) response in apolipoprotein E-deficient mice. Curr Eye Res. 2003;27(1):15–24. doi:10.1076/ceyr.27.2.15.15460.
   PubMed Web of Science ®Google Scholar
• Curcio CA. Mice with cholesterol in Bruch’s membrane: Have we arrived? Invest Ophthalmol Vis Sci. 2014;55(11):7296. doi:10.1167/iovs.14-15858.
   PubMed Web of Science ®Google Scholar
• Su F, Kozak KR, Imaizumi S, Gao F, Amneus MW, Grijalva V, Ng C, Wagner A, Hough G, Farias-Eisner G, et al. Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proc Natl Acad Sci U S A. 2010;107(46):19997–20002. doi:10.1073/pnas.1009010107.
   PubMed Web of Science ®Google Scholar
• Smith DD, Tan X, Tawfik O, Milne G, Stechschulte DJ, Dileepan KN. Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production. J Physiol Pharmacol. 2010;61(3):309–16.
   PubMed Web of Science ®Google Scholar
• Meyer CH, Holz FG. Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: Ranibizumab and bevacizumab. Eye (Lond). 2011;25(6):661–72. doi:10.1038/eye.2011.66.
   PubMed Web of Science ®Google Scholar
• Maguire MG, Daniel E, Shah AR, Grunwald JE, Hagstrom SA, Avery RL, Huang J, Martin RW, Roth DB, Castellarin AA, et al. Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2013;120(10):2035–41. doi:10.1016/j.ophtha.2013.03.017.
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Rudolf M, Funk M, Hofmann-Rummelt C, Franz-Haas N-S, Aherrahrou Z, Schlo¨tzer-Schrehardt U. Ultrastructural changes in a murine model of graded Bruch membrane lipoidal degeneration and corresponding VEGF164 detection. Invest Ophthalmol Vis Sci. 2008;49(1):390–98. doi:10.1167/IOVS.07-0227.
   PubMed Web of Science ®Google Scholar
• Rudolf M, Curcio CA. Esterified cholesterol is highly localized to Bruch’s membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J Histochem Cytochem. 2009;57(8):731–39. doi:10.1369/jhc.2009.953448.
   PubMed Web of Science ®Google Scholar
• Vogt SD, Barnum SR, Curcio CA, Read RW. Distribution of complement anaphylatoxin receptors and membrane-bound regulators in normal human retina. Exp Eye Res. 2006;83:834–40. doi:10.1016/j.exer.2006.04.002.
   PubMed Web of Science ®Google Scholar
• Lucocq JM. Efficient quantitative morphological phenotyping of genetically altered organisms using stereology. Transgenic Res. 2007;16(2):133–45. doi:10.1007/s11248-006-9048-9.
   PubMed Web of Science ®Google Scholar
• Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, Mobley JA, Curcio CA, Koch K-W. Abundant lipid and protein components of drusen. PLoS ONE. 2010;5(4):e10329. doi:10.1371/journal.pone.0010329.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Messinger JD, Sloan KR, McGwin G Jr, Medeiros NE, Spaide RF. Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: Morphology, prevalence, topography, and biogenesis model. Retina. 2013;33(2):265–76. doi:10.1097/IAE.0b013e31827e25e0.
   PubMed Web of Science ®Google Scholar
• Picard E, Houssier M, Bujold K, Sapieha P, Lubell W, Dorfman A, Racine J, Hardy P, Febbraio M, Lachapelle P, et al. CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits. Aging (Albany NY). 2010;2(12):981–89. doi:10.18632/aging.v2i12.
   PubMedGoogle Scholar
• Anderson MD, Dawson WW, Martinez-Gonzalez J, Curcio CA. Drusenoid lesions and lipid-filled retinal pigment epithelium cells in a rhesus macula. Vet Ophthalmol. 2006;9(3):201–07. doi:10.1111/j.1463-5224.2006.00463.x.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Zanzottera EC, Ach T, Balaratnasingam C, Freund KB. Activated retinal pigment epithelium, an optical coherence tomography biomarker for progression in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2017;58(6):BIO211–BIO26.
   PubMed Web of Science ®Google Scholar
• Averill MM, Kim EJ, Goodspeed L, Wang S, Subramanian S, Den Hartigh LJ, Tang C, Ding Y, Reardon CA, Getz GS, et al. The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. PLoS One. 2014;9(10):e109252. doi:10.1371/journal.pone.0109252.
   PubMed Web of Science ®Google Scholar
• Zeiss CJ. Animals as models of age-related macular degeneration: An imperfect measure of the truth. Vet Pathol. 2010;47(3):396–413. doi:10.1177/0300985809359598.
   PubMed Web of Science ®Google Scholar
• Pennesi ME, Neuringer M, Courtney RJ. Animal models of age related macular degeneration. Mol Aspects Med. 2012;33(4):487–509. doi:10.1016/j.mam.2012.06.003.
   PubMed Web of Science ®Google Scholar
• Jiang M, Esteve-Rudd J, Lopes VS, Diemer T, Lillo C, Rump A, Williams DS. Microtubule motors transport phagosomes in the RPE, and lack of KLC1 leads to AMD-like pathogenesis. J Cell Biol. 2015;210(4):595–611. doi:10.1083/jcb.201410112.
   PubMed Web of Science ®Google Scholar
• Heiduschka P, Fietz H, Hofmeister S, Schultheiss S, Mack AF, Peters S, Ziemssen F, Niggemann B, Julien S, Bartz-Schmidt KU, et al. Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci. 2007;48(6):2814–23. doi:10.1167/iovs.06-1171.
   PubMed Web of Science ®Google Scholar
• Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, Lallone R, Fogelman AM. Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 2002;105(3):290–92. doi:10.1161/hc0302.103711.
   PubMed Web of Science ®Google Scholar
• White CR, Datta G, Mochon P, Zhang Z, Kelly O, Curcio C, Parks D, Palgunachari M, Handattu S, Gupta H, et al. Vasculoprotective effects of apolipoprotein mimetic peptides: An evolving paradigm in HDL therapy. Vasc Dis Prev. 2009;6:122–30. doi:10.2174/1567270001006010122.
   PubMedGoogle Scholar
• Navab M, Chattopadhyay A, Hough G, Meriwether D, Fogelman SI, Wagner AC, Grijalva V, Su F, Anantharamaiah GM, Hwang LH, et al. Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis. J Lipid Res. 2015;56(4):871–87. doi:10.1194/jlr.M056614.
   PubMed Web of Science ®Google Scholar
• Nguyen SD, Javanainen M, Rissanen S, Zhao H, Huusko J, Kivelä AM, Ylä-Herttuala S, Navab M, Fogelman AM, Vattulainen I, et al. Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation. J Lipid Res. 2015;56(6):1206–21. doi:10.1194/jlr.M059485.
   PubMed Web of Science ®Google Scholar
• Moreira EF, Larrayoz IM, Lee JW, Rodriguez IR. 7-Ketocholesterol is present in lipid deposits in the primate retina: Potential implication in the induction of VEGF and CNV formation. Invest Ophthalmol Vis Sci. 2009;50(2):523–32. doi:10.1167/iovs.08-2373.
   PubMed Web of Science ®Google Scholar
• Tamai K, Spaide RF, Ellis EA, Iwabuchi S, Ogura Y, Armstrong D. Lipid hydroperoxide stimulates subretinal choroidal neovascularization in the rabbit. Exp Eye Res. 2002;74(2):301–08. doi:10.1006/exer.2001.1121.
   PubMed Web of Science ®Google Scholar
• Baba T, Bhutto IA, Merges C, Grebe R, Emmert D, McLeod DS, Armstrong D, Lutty GA. A rat model for choroidal neovascularization using subretinal lipid hydroperoxide Injection. Am J Pathol. 2010;176(6):3085–97. doi:10.2353/ajpath.2010.090989.
   PubMed Web of Science ®Google Scholar
• Dashti N, McGwin G Jr, Owsley C, Curcio CA. Plasma apolipoproteins and risk for age-related maculopathy. Br J Ophthalmol. 2006;90:1028–33. doi:10.1136/bjo.2006.093856.
   PubMed Web of Science ®Google Scholar
• Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G. Garber D, et al. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation. 2004;109(25):3215–20. doi:10.1161/01.CIR.0000134275.90823.87.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Millican CL. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol. 1999;117(3):329–39. doi:10.1001/archopht.117.3.329.
   PubMedGoogle Scholar
• Weber C, Noels H. Atherosclerosis: Current pathogenesis and therapeutic options. Nat Med. 2011;17(11):1410–22. doi:10.1038/nm.2538.
   PubMed Web of Science ®Google Scholar
• Kruth HS. Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles. Curr Opin Lipidol. 2011;22(5):386–93. doi:10.1097/MOL.0b013e32834adadb.
   PubMed Web of Science ®Google Scholar
• Vavvas DG, Daniels AB, Kapsala ZG, Goldfarb JW, Ganotakis E, Loewenstein JI, Young LH, Gragoudas ES, Eliott D, Kim IK, et al. Regression of some high-risk features of age-related macular degeneration (AMD) in patients receiving intensive statin treatment. EBioMed. 2016;5:198–203. doi:10.1016/j.ebiom.2016.01.033.
   PubMed Web of Science ®Google Scholar
• Apte RS. Targeting tissue lipids in age-related macular degeneration. EBioMed. 2016;5:26–27. doi:10.1016/j.ebiom.2016.02.003.
   PubMed Web of Science ®Google Scholar